Peter MacCallum Cancer Centre Expands Cancer Research Efforts with Automation Tool from Caliper Life Sciences
News May 29, 2009
Caliper Life Sciences, Inc. has announced a collaboration with the Peter MacCallum Cancer Centre (PMCC), based in Melbourne, Victoria, Australia. PMCC is using Caliper’s Staccato automation system to perform oncology related lab discovery experiments in less time, leading to a better understanding of how to treat and prevent cancer through gene knockdown therapies.
“We would be unable to perform this type of large scale research without the Staccato workstation from Caliper,” said Dr. Kaylene Simpson, manager of the Functional Genomics Group at PMCC. “The instrument helps us work toward our primary goals: to identify genes that regulate cancer cell growth, survival, and proliferation, and responses to drug targets.”
The Functional Genomics Group at PMCC is funded by the Australian Cancer Research Foundation (ACRF) and provides Australian research institutes with access to large scale, high throughput RNAi gene knockdown technology that aids cancer research. By eliminating a gene’s ability to express, gene knockdown techniques may uncover ways to silence specific genes associated with cancer, leading to new forms of treatment.
Researchers at PMCC are currently working with the Dharmacon entire human and mouse genome collections (~21,000 genes), attempting to knockdown each one. The Staccato enables the researcher to work through these gene sets in a systematic and reproducible way.
“The Peter MacCallum Cancer Centre’s decision to rely on the Staccato reinforces Caliper’s position as a leading provider of automation solutions for the life sciences industry,” said Kevin Hrusovsky, CEO of Caliper Life Sciences. “Caliper has made significant strides in helping our customers with oncology research. From automation to imaging and tumor models, Caliper provides researchers with the tools to conduct quality oncology research.”
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Chemists Design 'Mini-ecosystems' to Test Drug FunctionNews
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018